SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-15-001901
Filing Date
2015-05-13
Accepted
2015-05-13 15:58:49
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 593618
2 ex31-1.htm EX-31.1 16603
3 ex31-2.htm EX-31.2 16403
4 ex32-1.htm EX-32.1 7743
  Complete submission text file 0001493152-15-001901.txt   5809972

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE immy-20150331.xml EX-101.INS 737192
6 XBRL SCHEMA FILE immy-20150331.xsd EX-101.SCH 56670
7 XBRL CALCULATION FILE immy-20150331_cal.xml EX-101.CAL 76288
8 XBRL DEFINITION FILE immy-20150331_def.xml EX-101.DEF 226501
9 XBRL LABEL FILE immy-20150331_lab.xml EX-101.LAB 411493
10 XBRL PRESENTATION FILE immy-20150331_pre.xml EX-101.PRE 318862
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 15858289
SIC: 2834 Pharmaceutical Preparations